The Additional Financing on Vaccines for the Liberia COVID-19 Emergency Response Project provides upfront financing to help the government purchase and deploy COVID-19 vaccines that meet the Bank’s vaccine approval criteria (VAC), strengthen relevant health systems that are necessary for a successful deployment, and prepare for future emergencies. The proposed additional financing will help vaccinate 60 percent of the 52 percent of the country’s population currently eligible for vaccination. This AF would support the costs of expanding activities of the original Emergency COVID-19 Response Project.